Nigerian pharmaceutical companies now share 65
percent of the West African market, having so far invested N300 billion
in machinery and quality upgrade in an effort to end drug importation
into the country, estimated at $700 million.
Four companies have so far obtained the World Health
Organisation (WHO) pre-qualification, while four others are in line to
obtain same, in an effort to dig into the local market and remain
competitive in the international scene, BusinessDay can report.
 |
| drugs |
Evans Medical, Chi Pharmaceuticals,
May&Baker and Swiss Pharma have already obtained prequalification.
These four companies, alongside four others that are processing the WHO
prequalification, have invested $50 million in different levels of
upgrade in the last five years, BusinessDay has learnt.
Similarly, ten drug firms have met the
requirements of the International Standards Organisation (ISO), which
now enables them to raise their competitive capacity in the
international market. The companies that have achieved this feat
include Afrabchem Limited, Chi Pharmaceuticals, Dana Pharmaceuticals,
Drugfield Pharmaceuticals, Emzor Pharmaceuticals, Fidson Healthcare, SKG
Pharma Limited, Evans Medical and Swiss Pharma, as well as May &Baker.
“Nigerian pharmaceutical manufacturers
